BridgeMD
Tests treatment safety and results for Lyme Disease
Official title A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
ClinicalTrials.gov ID: NCT07561294
What this study is testing
What is mRNA-1982?
mRNA-1982 is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for lyme disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical study will evaluate the safety, reactogenicity, and immunogenicity of monovalent mRNA-1982, a messenger ribonucleic acid (mRNA) vaccine to prevent Lyme disease in healthy adults aged 18 to 70 years old.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- In good general health in the opinion of the investigator as determined by medical evaluation including medical history and physical examination at...
- Contraceptive use by participants should be consistent with local regulations regarding the methods of contraception for those participating in...
You likely can't join if
- History of anaphylaxis or severe hypersensitivity reaction requiring medical intervention after receipt of any mRNA vaccine or therapeutic or any...
- Have chronic illness related to Lyme disease or an active symptomatic Lyme disease infection as suspected or diagnosed by a physician.
- Received treatment for Lyme disease within the prior 3 months.
- Previously vaccinated against Lyme disease or participated in the past in any vaccine study for Lyme disease.
- Had a tick bite within 4 weeks prior to Day 1. Note: Additional inclusion/exclusion criteria may apply, per protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Truro, Nova Scotia, Canada
- Sarnia, Ontario, Canada
- Stouffville, Ontario, Canada
- Toronto, Ontario, Canada
- Joliette, Quebec, Canada
- Sherbrooke, Quebec, Canada
- Victoriaville, Quebec, Canada
- Québec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Truro, Nova Scotia, Canada; Sarnia, Ontario, Canada; Stouffville, Ontario, Canada; Toronto, Ontario, Canada; Joliette, Quebec, Canada; Sherbrooke, Quebec, Canada and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.